Fibromyalgia Pipeline Review, H1 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Fibromyalgia - Pipeline Review, H1 2017" report to their offering.

Pharmaceutical and Healthcare disease pipeline guide Fibromyalgia - Pipeline Review, H1 2017, provides an overview of the Fibromyalgia (Central Nervous System) pipeline landscape.

Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. Symptoms include fatigue, depression, headaches, and pain or cramping in the lower abdomen. The predisposing factors include family history, rheumatoid arthritis or lupus. Treatment includes pain relievers, antidepressants and anti-seizure drugs.

Fibromyalgia (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Fibromyalgia Overview
  3. Therapeutics Development
  4. Pipeline Products for Fibromyalgia - Overview
  5. Pipeline Products for Fibromyalgia - Comparative Analysis
  6. Fibromyalgia - Therapeutics under Development by Companies
  7. Fibromyalgia - Therapeutics under Investigation by Universities/Institutes
  8. Fibromyalgia Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Fibromyalgia - Products under Development by Companies
  13. Fibromyalgia - Products under Investigation by Universities/Institutes
  14. Fibromyalgia - Companies Involved in Therapeutics Development
  • Astellas Pharma Inc
  • Daiichi Sankyo Company Ltd
  • Immune Therapeutics Inc
  • Innovative Med Concepts LLC
  • Jiangsu Hengrui Medicine Co Ltd
  • KPI Therapeutics Inc
  • Merck & Co Inc
  • Pfizer Inc
  • SWITCH Biotech LLC
  • Theravance Biopharma Inc
  • Vitality Biopharma Inc
  • Zynerba Pharmaceuticals Inc

For more information about this report visit http://www.researchandmarkets.com/research/sdzft2/fibromyalgia

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs, Musculoskeletal Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs, Musculoskeletal Disorders Drugs